Fuji, Japan

Toshio Inagi

This inventor holds 16 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Iontophoresis Technology. Top assignees: Kowa Company Limited, Tokyo University of Science Foundation, Kabushiki Kaisha Toyota Chuo Kenkyusho. Active years: 1982-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshio Inagi. Retrieved from https://idiyas.com/inventor/toshio-inagi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 56.3

 

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 130(Granted Patents)


Location History:

  • Tokorozawa, JP (1984)
  • Hachioji, JP (1982 - 1985)
  • Mishima, JP (1994 - 2012)
  • Fuji, JP (2011 - 2013)

Company Filing History:


Years Active: 1982-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Iontophoresis
Medicinal Compositions
Electrotherapeutic Device
Breast Cancer Treatment
Solid Dispersion Composition
Local Anesthetic
Hydrophilic Adhesive
Anti-Inflammatory Gel
Powder Preparation
External Preparation
Skin Healing
Adhesive Base Material
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Toshio Inagi

Introduction

Toshio Inagi is a prominent inventor based in Fuji, Japan, known for his significant contributions to medical technology. With a total of 16 patents to his name, Inagi has focused on developing innovative solutions for treating breast cancer and mastitis. His work exemplifies the intersection of science and technology in addressing critical health issues.

Latest Patents

Inagi's latest patents include an iontophoretic preparation designed for the treatment of breast cancer and/or mastitis. This preparation aims to enhance the therapeutic effect of iontophoretic treatments by using a nonsteroidal anti-inflammatory analgesic agent and/or an anticancer agent. The method involves topically administering an electrolyte through the nipple into the mammary gland, followed by the application of a donor to facilitate the delivery of the active ingredient via electric current. This innovative approach allows for efficient treatment of breast cancer and mastitis by ensuring that the active ingredients effectively reach the mammary gland.

Career Highlights

Throughout his career, Toshio Inagi has worked with notable organizations, including Kowa Company Limited and the Tokyo University of Science Educational Foundation Administrative Organization. His experience in these institutions has contributed to his expertise in medical innovations and patent development.

Collaborations

Inagi has collaborated with several professionals in his field, including Makoto Kanebako and Toyojiro Muramatsu. These collaborations have further enriched his research and development efforts, leading to advancements in medical treatments.

Conclusion

Toshio Inagi's work in developing iontophoretic preparations for breast cancer and mastitis showcases his commitment to improving healthcare through innovation. His contributions continue to impact the medical field positively, demonstrating the importance of research and development in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…